The Problem: Transformation Programs Devolve Into Disconnected Projects
Large pharma transformations — ERP migrations, digital lab initiatives, commercial excellence programs, AI-at-scale deployments — comprise 10-30+ interdependent workstreams. Programs fail when they devolve into collections of independent projects with no integration layer. Warning signs: dependencies managed reactively, no portfolio-level risk view, benefits defined but not tracked, steering committees reviewing status but not making decisions.
The Solution: Strategic Program Orchestration
- Strategic alignment: Continuous validation that program outputs map to business outcomes
- Dependency management: Cross-workstream integration planning and conflict resolution
- Benefits tracking: Quantified value realization tied to specific program milestones
- Governance architecture: Tiered decision-making from workstream leads to steering committee
- Risk aggregation: Portfolio-level risk view identifying systemic threats across workstreams
- Resource optimization: Shared resource allocation across competing demands
The Approach: Integration Over Administration
A program manager's primary job isn't managing tasks — it's managing interdependencies and ensuring that the sum of project outputs equals the intended business transformation.
How ANG Associates Can Help
ANG Associates provides experienced program managers for large-scale pharma transformation initiatives. We establish the governance structures, dependency management processes, and benefits tracking mechanisms that transform a collection of projects into a coherent program delivering strategic outcomes. Our program managers have led multi-year, multi-vendor transformations across Swiss and EU pharma organizations — they understand the scale, the stakeholders, and the regulatory context.